Clinical Trial Update: Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney [Phase 2]

View source ↗

Summary

This Phase 2 trial compared belatacept with cyclosporine in kidney transplant recipients to assess safety and efficacy. Results were posted in January 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Rejection
• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• belatacept (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Graft Rejection, Kidney Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2014-01-13